ClinicalTrials.Veeva

Menu

Moderate vs Deep Neuromuscular Block on Biotrauma During Laparoscopy

A

Ajou University School of Medicine

Status

Completed

Conditions

Pneumoperitoneum

Treatments

Drug: Deep neuromuscular block
Drug: Moderate neuromuscular block

Study type

Interventional

Funder types

Other

Identifiers

NCT03576118
AJIRB-MED-OBS-18-115

Details and patient eligibility

About

The purposes of this study is to investigate the effects of moderate vs. deep neuromuscular block on respiratory mechanics and biotrauma in patients with intraoperative protective lung ventilation for laparoscopy.

Full description

Mechanical ventilation results in the disruption of the alveolar-capillary barrier and increased permeability, a hallmark of experimental ventilator-induced lung injury. These mechanical forces also induce an increase in the concentrations of inflammatory cytokines.

The benefits of deep neuromuscular blocks for laparoscopic procedures are controversial and most of the studies undertaken have only sought to improve surgical conditions. Theoretically, deep neuromuscular block permits a lower abdominal insufflation pressure, which leads to better respiratory mechanics and gas exchange. The investigators examined the effects of moderate vs. deep neuromuscular block on respiratory mechanics and biotrauma in patients with intraoperative protective lung ventilation for laparoscopy. The investigators hypothesized that deep neuromuscular block (PTC 1 or 2) and low pressure pneumoperitoneum (8 mmHg) would improve respiratory mechanics and reduce inflammatory processes associated with biotrama during mechanical ventilation compared with moderate neuromuscular block (TOF count 1 or 2 ) and standard pressure pneumoperitoneum (12-15 mmHg).

Enrollment

74 patients

Sex

All

Ages

25 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA physical status I or II, aged 25 to 80 years, scheduled for laparoscopic surgery with trendelenburg position

Exclusion criteria

  • cerebrovascular disease
  • uncontrolled hypertension, asthma, COPD
  • neuromuscular disorder
  • patients who have had abdominal surgery
  • morbid obesity (body mass index > 35 kg/m2)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

74 participants in 2 patient groups

Deep neuromuscular block
Experimental group
Description:
Deep neuromuscular relaxation and low pressure pneumoperitoneum
Treatment:
Drug: Deep neuromuscular block
Moderate neuromuscular block
Active Comparator group
Description:
Moderate neuromuscular relaxation and standard pressure pneumoperitoneum
Treatment:
Drug: Moderate neuromuscular block

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems